These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35523260)

  • 1. The profile of cognitive impairment and hemodynamic compromise in moyamoya: a single-center prospective cohort study.
    Kronenburg A; Deckers PT; van den Berg E; van Schooneveld MM; Vonken EJ; van der Zwan A; van Berckel BNM; Yaqub M; Otte W; Klijn CJM; Braun KPJ
    J Neurosurg; 2023 Jan; 138(1):173-184. PubMed ID: 35523260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
    Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
    J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcome, Cognition, and Cerebrovascular Reactivity after Surgical Treatment for Moyamoya Vasculopathy: A Dutch Prospective, Single-Center Cohort Study.
    Deckers PT; Kronenburg A; van den Berg E; van Schooneveld MM; Vonken EPA; Otte WM; van Berckel BNM; Yaqub M; Klijn CJM; van der Zwan A; Braun KPJ
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular Reactivity Measured with ASL Perfusion MRI, Ivy Sign, and Regional Tissue Vascularization in Moyamoya.
    Kronenburg A; Bulder MMM; Bokkers RPH; Hartkamp NS; Hendrikse J; Vonken EJ; Kappelle LJ; van der Zwan A; Klijn CJM; Braun KPJ
    World Neurosurg; 2019 May; 125():e639-e650. PubMed ID: 30716498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of cerebrovascular reactivity in pediatric patients with cerebral vasculopathy using blood oxygen level-dependent MRI.
    Han JS; Mikulis DJ; Mardimae A; Kassner A; Poublanc J; Crawley AP; deVeber GA; Fisher JA; Logan WJ
    Stroke; 2011 May; 42(5):1261-9. PubMed ID: 21493907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H
    Roder C; Haas P; Fudali M; Milian M; Ernemann U; Meyer PT; Tatagiba M; Khan N
    Neurosurg Rev; 2020 Dec; 43(6):1615-1622. PubMed ID: 31728848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presurgical Magnetic Resonance Imaging Indicators of Revascularization Response in Adults With Moyamoya Vasculopathy.
    L Waddle S; Garza M; Davis LT; V Chitale R; R Fusco M; A Lee C; Patel NJ; Kang H; Jordan LC; Donahue MJ
    J Magn Reson Imaging; 2022 Oct; 56(4):983-994. PubMed ID: 35289460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fronto-Parietal and White Matter Haemodynamics Predict Cognitive Outcome in Children with Moyamoya Independent of Stroke.
    Choi EJ; Westmacott R; Kirkham FJ; Robertson A; Muthusami P; Shroff M; Moharir M; Williams T; Dirks P; MacGregor D; Slim M; Pulcine E; Bhathal I; Kaseka ML; Kassner A; Logan W; deVeber G; Dlamini N
    Transl Stroke Res; 2022 Oct; 13(5):757-773. PubMed ID: 35338434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cerebrovascular reactivity with steal phenomenon is associated with increased diffusion in white matter of patients with Moyamoya disease.
    Conklin J; Fierstra J; Crawley AP; Han JS; Poublanc J; Mandell DM; Silver FL; Tymianski M; Fisher JA; Mikulis DJ
    Stroke; 2010 Aug; 41(8):1610-6. PubMed ID: 20576954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and Long-Term MRI Assessed Hemodynamic Changes in Pediatric Moyamoya Patients After Revascularization.
    Zhao MY; Tong E; Duarte Armindo R; Fettahoglu A; Choi J; Bagley J; Yeom KW; Moseley M; Steinberg GK; Zaharchuk G
    J Magn Reson Imaging; 2024 Apr; 59(4):1349-1357. PubMed ID: 37515518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular Reactivity Mapping Using Resting-State BOLD Functional MRI in Healthy Adults and Patients with Moyamoya Disease.
    Liu P; Liu G; Pinho MC; Lin Z; Thomas BP; Rundle M; Park DC; Huang J; Welch BG; Lu H
    Radiology; 2021 May; 299(2):419-425. PubMed ID: 33687287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
    Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Angiographic Appearances of Moyamoya Disease Detected with 3-Dimensional Rotational Digital Subtraction Angiography Imaging Showing the Hemodynamic Status.
    Karakama J; Nariai T; Hara S; Hayashi S; Sumita K; Inaji M; Tanaka Y; Wagatsuma K; Ishii K; Nemoto S; Maehara T
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2147-2157. PubMed ID: 29653803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.
    Xu D; Yu X; Hu J; Yu Y; Wang L; Jiang B; Zhang M
    Eur Radiol; 2024 Jul; 34(7):4596-4606. PubMed ID: 38092950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral improvement of cerebrovascular reactivity and TIA frequency after unilateral revascularization surgery in moyamoya vasculopathy.
    Deckers PT; van Hoek W; Kronenburg A; Yaqub M; Siero JCW; Bhogal AA; van Berckel BNM; van der Zwan A; Braun KPJ
    Neuroimage Clin; 2021; 30():102684. PubMed ID: 34215154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of Cerebrovascular Reactivity as Blood Oxygen Level-Dependent Magnetic Resonance Imaging Signal Response to a Hypercapnic Stimulus in Mechanically Ventilated Patients.
    Venkatraghavan L; Poublanc J; Han JS; Sobczyk O; Rozen C; Sam K; Duffin J; Mikulis DJ; Fisher JA
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):301-308. PubMed ID: 28967593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-Year Clinical, Cerebral Hemodynamic, and Cognitive Outcomes of Adult Patients Undergoing Medication Alone for Symptomatically Ischemic Moyamoya Disease Without Cerebral Misery Perfusion: A Prospective Cohort Study.
    Miyoshi K; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
    Neurosurgery; 2019 Jun; 84(6):1233-1241. PubMed ID: 29850833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease.
    Liu Z; He S; Xu Z; Duan R; Yuan L; Xiao C; Yi Z; Wang R
    BMC Neurol; 2020 Aug; 20(1):302. PubMed ID: 32799829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cerebrovascular reserve in patients with cerebrovascular diseases using resting-state MRI: A feasibility study.
    Taneja K; Lu H; Welch BG; Thomas BP; Pinho M; Lin D; Hillis AE; Liu P
    Magn Reson Imaging; 2019 Jun; 59():46-52. PubMed ID: 30849484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.